ROYAL BANK OF CANADA - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AD2. A total of 54 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$3,513,000
+1.5%
3,411,000
-3.0%
0.00%0.0%
Q1 2024$3,462,000
-7.8%
3,517,000
-1.4%
0.00%0.0%
Q4 2023$3,753,000
+5.5%
3,568,000
-2.1%
0.00%0.0%
Q3 2023$3,557,000
+29.9%
3,643,000
+25.5%
0.00%0.0%
Q2 2023$2,738,000
-10.7%
2,903,000
-14.1%
0.00%0.0%
Q1 2023$3,066,000
-41.3%
3,378,000
-40.2%
0.00%0.0%
Q4 2022$5,219,000
+17.8%
5,653,000
+26.1%
0.00%0.0%
Q3 2022$4,430,0004,483,0000.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
STEELHEAD PARTNERS LLC 55,490,000$58,672,6293.04%
CSS LLC/IL 31,931,000$33,726,3851.95%
Sonora Investment Management Group, LLC 12,643,000$13,318,5161.08%
MACKAY SHIELDS LLC 30,030,000$31,723,8600.93%
CAMDEN ASSET MANAGEMENT L P /CA 26,400,000$27,772,8000.86%
SHENKMAN CAPITAL MANAGEMENT INC 10,933,000$11,720,1510.84%
DeepCurrents Investment Group LLC 20,000,000$21,105,4590.76%
Magnetar Financial LLC 28,500,000$30,082,4230.76%
TENOR CAPITAL MANAGEMENT Co., L.P. 32,000,000$33,784,3000.60%
SSI INVESTMENT MANAGEMENT LLC 6,474,000$6,810,6480.52%
View complete list of IONIS PHARMACEUTICALS INC shareholders